Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.47)
# 3,505
Out of 5,044 analysts
173
Total ratings
45.21%
Success rate
-1.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Maintains: Equal-Weight | $3 → $4 | $5.17 | -22.63% | 16 | Jul 15, 2025 | |
| MDT Medtronic | Maintains: Overweight | $98 → $107 | $93.23 | +14.77% | 10 | Jul 15, 2025 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $160 → $147 | $182.67 | -19.53% | 17 | Jul 15, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $101.14 | -6.07% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $545.39 | +19.18% | 13 | Dec 2, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.02 | -14.41% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $129.71 | -26.76% | 12 | Feb 28, 2024 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $74.82 | +13.61% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $45.26 | -66.86% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $324.34 | +5.75% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $1.98 | +607.07% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $22.86 | +109.97% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $82.19 | +24.10% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $100.97 | -42.56% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $15.20 | +31.58% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $69.23 | +89.22% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $126.61 | +5.05% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $375.93 | -41.48% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $130.58 | +189.48% | 2 | Feb 25, 2022 |
Sight Sciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $3 → $4
Current: $5.17
Upside: -22.63%
Medtronic
Jul 15, 2025
Maintains: Overweight
Price Target: $98 → $107
Current: $93.23
Upside: +14.77%
iRhythm Technologies
Jul 15, 2025
Maintains: Overweight
Price Target: $160 → $147
Current: $182.67
Upside: -19.53%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $101.14
Upside: -6.07%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $545.39
Upside: +19.18%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.02
Upside: -14.41%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $129.71
Upside: -26.76%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $74.82
Upside: +13.61%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $45.26
Upside: -66.86%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $324.34
Upside: +5.75%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $1.98
Upside: +607.07%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $22.86
Upside: +109.97%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $82.19
Upside: +24.10%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $100.97
Upside: -42.56%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $15.20
Upside: +31.58%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $69.23
Upside: +89.22%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $126.61
Upside: +5.05%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $375.93
Upside: -41.48%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $130.58
Upside: +189.48%